Facebook
Twitter
LinkedIn
Email
 |
Checking for direct PDF access through Ovid | |
Excerpt
A letter to our readers:
We regret to inform you that The Journal of Bone and Joint Surgery must retract “Skin-Derived Fibroblasts for the Treatment of Refractory Achilles Tendinosis: Preliminary Short-Term Results” by H. Obaid, A. Clarke, P. Rosenfeld, C. Leach, and D. Connell. The citation for this article is J Bone Joint Surg Am. 2012 Feb 1;94(3):193-200.
The study was initially misclassified as a clinical trial by Dr. Connell, in error, and this error was compounded by the same misclassification by the Joint Royal National Orthopaedic Hospital (RNOH) and Institute of Orthopaedics and Musculoskeletal Science (IOMS) Research Ethics Committee. Thus, the ethics approval for this study that was given by the Joint RNOH/IOMS Research Ethics Committee was issued in error.
Initial allegations regarding the conduct of this study largely resulted from the misclassification. Additionally, we have it on authority that records of the research findings were retained and are available.
The study did not meet our ethics policy criterion regarding institutional review board (IRB) approval or approval by a similar ethics board, and thus the article must be retracted.
Respectfully submitted,
JOURNAL/jbjs/04.02/00004623-201504150-00008/math_8MM1/v/2017-07-21T231611Z/r/image-jpeg
Marc F. Swiontkowski, MD
Editor-in-Chief
JOURNAL/jbjs/04.02/00004623-201504150-00008/math_8MM2/v/2017-07-21T231611Z/r/image-jpeg
Vernon T.
